Antibodies
24 August 2009
Seattle Genetics Completes Enrollment of Brentuximab Vedotin (SGN-35) Pivotal Trial for Patients with Hodgkin Lymphoma18 August 2009
GLAXOSMITHKLINE AND GENMAB ANNOUNCE RESULTS FROM A STUDY OF ARZERRA IN RITUXIMAB REFRACTORY FOLLICULAR NHL18 August 2009
Neurimmune Therapeutics Announces Advancement of Alzheimer’s Program into Preclinical Development14 August 2009
Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting14 August 2009
Immunomedics Announces FDA Allowance of Investigational New Drug Application for Milatuzumab-Doxorubicin Conjugate5 August 2009
FDA: Cancer Warnings Required for TNF Blockers3 August 2009
Merck KGaA Presented New Data On the Combination of Erbitux with Standard First-Line Therapy in Patients with NSCLC31 July 2009
Merck KGaA Has Requested Re-examination of the CHMP Opinion for Erbitux in Non-Small Cell Lung Cancer30 July 2009
GLAXOSMITHKLINE AND GENMAB ANNOUNCE TOP-LINE RESULTS FOR OFATUMUMAB IN RHEUMATOID ARTHRITISNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports